Aim: Disturbancesofthe D4 receptor subtypehave been implicated in the genesisofabroad range of psychiatric disorders. In ordertoassess thesuitability of aradioiodinated analogue of theD4-selective ligandFAUC 113 for tracer studies in vivo, we investigated the in-vivo stability, biodistribution andb rain-uptake of 7-131 I-FAUC 113 in Sprague-Dawley rats. Methods: Radiolabelling wascarried out with high radiochemicalyield andspecific activity. After intravenous injection,b lood andt issue samples, taken at designated time intervals, were collected for analysis. Analysesofmetaboliteswereperformedbyradiohplc andradio-tlc. For in-vivoevaluation,sagittal cryo-sectionsofthe rat brain wereinvestigatedbyin-vitro andexvivo autoradiography on aµ -Imagers ystem. Results: 7-131 I-FAUC 113 wasrapidly clearedfrom blood. Highest uptake wasobserved in kidney (0.603±0.047% ID/g, n=4) andliver(0.357±0.070% ID/g, n=4) at 10 min p.i.;7 -131 I-FAUC 113 displayed rapid uptake (0.21-0.26% ID/g)and fast clearance in various brainregionsc onsistent with the determined logP-value of 2.36±0.15 (n=4). In-vivo stabilityof7-131
Bioverteilung von Radioiodmarkiertem FAUC 113: Bewertung eines potenziellen Radioligandenfür den DopaminD4-Rezeptormit Pyrazolo(1,5-a) -pyridinGrundkörper
T he dopamine D4 receptor subtype wasc loned (34) andc haracterized by receptor autoradiography of knock-out mice (6) or immunohistochemistryusing receptor-specificantibodies (1, 7, 24) . Itsprecise function andexact distribution in the centraln ervous system are of great interest.Alterationsa nd disturbances of the D4 receptor were implicated in the genesisa nd treatment of ab roadr ange of neurobehavioral andp sychiatric disorders such as novelty seeking, attention-deficit hyperactivity disordera nd schizophrenia (26, 35) . Ah igher densityo fD 4r eceptors wasf ound in postmortem brain tissueo f schizophrenic patients (32) ;h owever,t his wasnot supported by other studies (9, 31) . These discrepant findings could be explainedbythe lackofaselective D4 receptor radioligandwith highaffinity andselectivity to other dopamine receptors. As yet, dopamine D4 receptor concentrationsi n vitro can onlyb ed eterminedb yi ndirect binding studies,i nw hich the number of binding sitesd efinedw ith ³H-raclopride (D2/D3 antagonist) ares ubstracted from totalb inding (³H-nemonapride) ( 13, 32) . However, recentprogress hasbeen made by the synthesis of the firsts electivet ritiated D4 agonist as ar adioligandt om ore accurately characterizec ompetitiveb inding for agonists at the D4 receptor (22) .
Moreover,the lackofD4receptor selective radioligands suitablef or in-vivo imaging techniques especially hampers the non-invasive investigation of neurotransmission by single photon emission tomography (SPET) or positron emission tomography (PET). These methodologies serve as high-performanceimagingtools in nuclearm edicine foru nderstanding the Prante et al.
neurochemical basisand pathologyofneuropsychiatricd iseases (2) . Severalr eports concern 18 F-and 11 C-labelled ligands for the exploration of D4 receptor density in vivo by PETi ncluding 11 C-SDZ GLC 756 (3), methoxybenzamide derivatives ( 15, 36) , SB-235753 (4, 21) or 18 F-and 123 I-labelled pyrrolo-2,3-b-pyridines ( 8, 27, 33) . However,n one of theser adioligands hasb een provensuitable,because of poor specificity in vivo or undesirablep harmacological properties. Thus,dataonthe apparentlylow D4 receptor densitiesinthe brain arescarce andwerereported onlyinanalyses using insitu hybridization establishingr eceptor expression in the prefrontal cortex andhippocampus (17) . Furthermore,using autoradiography with 3 H-NGD 94-1 B max -values ranging from 9-30 fmol/mgindistinctbrain regions were reported (14, 30) .
As apartofour drug discoveryand SAR investigationsonselectivedopamine D4 receptor ligands (11, 16, 19, 20) , we developed FAUC 113asahigh affinitydopamine D4 receptor ligandw ith superior subtype selectivityw henc omparedt ot he corresponding indoled erivative ( 18) . Moreover,radioiodination of the lead compound FAUC 113i n7 -position lead to the corresponding 3-[4-(4-chlorophenyl)piperazin-1-yl]methyl-7-131 I-iodopyrazolo(1,5-a )pyridine I-FAUC1 13) under retention of high D4 receptor affinity (K i =2.6 nmol/l) ands ubtype selectivityi n vitro ( Fig. 1) (29) .
Theaim of the presentstudywas the investigation of biodistribution, in-vivo stabilitya nd brain uptakep atternso f 7-131 I-FAUC1 13 in ordert oa ssess the invivo propertieso ft his radioligand. We focused on the determination of brain uptake specificity of I-FAUC113 by the useof in-vitroand ex-vivo autoradiography.
Animals,material, methods
Na 131 I, product code IBSSO,w as obtained from Amersham (Braunschweig, Germany). Analytical gradec hemicalsa nd reagents were purchased from Sigma-Aldirch (Deisenhofen, Germany) or Research BiochemicalsI nternational( RBI, Sigma). Phosphate buffered saline (PBS), EDTA andT ween 20 were purchased from Invitrogen(Gibco, Karlsruhe, Germany). Radiothin layerchromatography(radio-TLC) was carriedout on silicagel-coatedplates(SIL 300, Macherey-Nagel,D üren, Germany). Radio-TLC wasd etected anda nalysed by electronic autoradiography (Instant Imager TM ,C anberraP ackard). Analytical radio-high performancel iquid chromatography (radio-HPLC) wasp erformedo n the following system: HPLCHewlett Packard( HP 1100)w ith quarternaryp ump and variablew avelength detector (254nm)connected to radio-HPLC-detector D505TR (CanberraPackard).
Computer analysis of HPLC data was performed with FLO-Ones oftware (CanberraP ackard). Radioactive tissuesamples were counted using aN aI(Tl)s zintillation counter (Caprac, Capintec).A utoradiography andw hite-lighti magingo fb rain slices wasp erformedo nt he real-time µ-Imager system (Biospace Instruments, France). Bq/µmol by radio-HPLC using aH P-RP-8 Eclipse column (125x4 mm,m ethanol/0.1m ol/la mmonium formate; 70:30, v/v,p H6 .8;0 .6 ml/min, k'=3.8). TheU Va bsorbancea t2 54 nm of authentic3 -(4-(4-chlorophenyl)-piperazin-1-yl) methyl-7-131 I-pyrazolo(1,5a )-pyridine (7- 131 I-FAUC113; 29) wasused as areference signaltodetermine the specific activity of 7-131 I-FAUC1 13 with ak nown Tissue distribution of radioiodinated FAUC 113 radioactivity considering the sensitivity limit of UV-detection (0.4 nmol).
Animals

Determinationofpartition coefficient (logP)
Thel ipophilicity of 7-[ 131 I]FAUC1 13 was assessed by determination of the water-octanol partition coefficientfollowing the procedure of Holschbach et al. (10) . Aftersolvent evaporation 7-131 I-FAUC113 wasdissolved in 1.0mln-octanol saturated with 50 mmol/lTris-HCl (pH 7.4). The phases were vigorouslymixed for 15 min afteraddition of 1.0ml50mmol/l Tris-HCl (pH 7.4). The solventphases were seperated with centrifugation at 3000 rpmfor 8min andaliquots of each phase (20 µl, n=3)wereused for radioactivity counting. Repeatedly,adefinedvolume of the octanol phase (100-500 µl) was re-extracted with the samevolumeoffresh 50 mmol/lTris-HCl (pH 7.4). Radioactivity determinationso fa liquots of each phase (20 µl, n=3)werecarriedout untilthe ratio of counts (cpm octanol /cpm buffer )was found to be invariant. Aconstant partition coefficient wasreached at least aftertwo re-extraction procedures. ThelogP-value of 7-131 I-FAUC 113 was2.36±0.15 (n=4), as determinedby four independent experiments: logP =log(cpm octanol /cpm buffer ).
In-vitroautoradiography
Female Sprague-Dawleyr atsw eighing 200-240 gw eres acrificed by decapitation (without anesthesia). Brains were removed andfrozen in cooled hexane at -70°C.Sagittalsectionsof20µmwerecut on acryostat microtome( HM550, Microm, Germany) andt haw-mounted on coveredg lass slides (Histobond ® ,M arienfeldG mbH,G ermany). The brain slices were carefullydriedat room temperature andp re-incubatedf or 5min in 50 mmol/l Tris-HCl buffer (pH 7.4) containing 120 mmol/lN aCl, 1m mol/l EDTA,5mmol/l MgCl 2 .P re-incubation wasrepeated onceand the sections were incubated at room temperature for 60 min in assayb uffer( 120 mmol/lN aCl, 1m mol/l EDTA,5mmol/l MgCl 2 )containing 4MBq 7-131 I-FAUC 113with or without the follow- I-FAUC 113i n1 00 µl (35-50 GBq/ µmol)inordertoassess the dependence of the amount of radiolabelledl igando nr egional brain uptakevalues. Ratsweresacrificed by rapid decapitation (without anesthesia) after designated periods (5, 10, 20 and40min).Bloodand tissuesamples were rapidlyremoved,measuredfor radioactivity andw eighed. Experiments were conducted on groups of at least three rats pert ime point, with results expressed as the %o f injected dosep er gram of wett issue (%ID/g). Forblockingstudies, rats received at ail-veinc oinjection of 7-131 I-FAUC1 13 in 50-100 µl PBSc ontaining 1m g/kg L-750,667.
Analyses of metabolitesinrat tissue samples
Thed etermination of radioactivem etabolites of 7-131 I-FAUC113 wascarriedout using blood samples (10 mina nd 20 min p.i.) andt issues amples of thyroid, frontal cortex andliver obtainedat20min post-injection unless otherwise indicated.5 0-100 mg of tissuewereextracted with 900µlcold methanol/dichloromethane (50:50, v/v) and homogenizedw ith as onifier.The solution wasc entrifugeda t5 000g for 10 mina nd the supernatantw as used for radio-TLC (CH 2 Cl 2 /MeOH;9 5:5, v/v) or an aliquot (100 µl) wase vaporated to dryness and injected into the radio-HPLC( HP-RP-8c olumn, 125x4mm,m ethanol/0.1m ol/la mmonium formate; 70:30, v/v,pH6.8;0.6 ml/ min).The eluate wasm onitoredf or radioactivity andUVabsorbanceat254nm. Analytical amounts of authentic 7-iodo-FAUC 113wereaddedtothe samples to prove the identity of non-metabolized radioactive 7-131 I-FAUC113.
Ex-vivo autoradiography of brain slices
Regional brain uptakeo f7 -131 I-FAUC1 13 wasv isualized by autoradiography of rat brain slices, usuallyobtainedfrom the same animals whichw ereu sed for the biodistributions tudies. Ratsw eres acrificed by decapitation at 10 minp .i.o f7 -131 I-FAUC 113 with (n=4) or without (n=6) 1mg/kg L-750667 in av olumeo f5 0-100 µl PBS. Thewhole brain wasremoved carefullyand frozeni nc ooled hexane at -70°C.S agittal sections of 20 µm were cuto nacryostat microtome (HM550, Microm, Germany)at -20°C andt haw-mounted on glassm icroscopes lides. Afterc ompletea ir-drying the radiolabeleds ectionsw erec overed by the solid scintillator sheet for autoradiography (µ-Imager, Biospace).Anatomic images of the sameslices were also obtainedbythe interlaced CCD of the µ-Imagersystem.These imageswereused for defining regions of interest (ROIs). TheR OIsw eret hent ransferred to the autoradiographic images allowing the quantification of these brain regions by using the autoradiographic intensities(Beta-Vision Software, Biospace).
Statistics
Theintensities of ROIs in autoradiographic images were obtainedascpm/mm². All experiments were performedintriplicate if not otherwise indicated.D ataa re expressed as mean ±SD. Thesignificance of differences in meansw as examinedu sing Student's t test for paireddata. pvalues<0.05 were consideredsignificant.
Results
Biodistributionand brainuptakeof 7-
I-FAUC 113
Following intravenous injection of 7-131 I-FAUC113 intoSprague-Dawleyrats, the time course of radioactivityw as determinedi ns everal tissues (Table 1) . 7-131 I-FAUC1 13 wasr apidlyc leared from the blood pool. At 10 minp .i., the highest uptakewas observedfor allorgansunderinvestigation.The radioactivityinthe kidney washighest,from thereon decreasing, clearance via the bladderbeing the main degradation pathway for 7-131 I-FAUC1 13. High uptakewas also observedinthe thyroidat10 min, indicating metabolic deiodination of the tracer followedb yt rapping of 131 I-iodide.B rain uptake of 7-131 I-FAUC1 13 revealed the highest value at 10 minp .i.f or cortical areas followedb ys triatum, brainstem and cerebellum. Fora ll these brain areas uptakev aluesr angedb etween 0.21 and0.26%ID/g (Fig. 2 ).
Lipophilicity and in vivo stability
We also determinedl ogPf or 7-131 I-FAUC 113 as an indicator for lipophilicity and blood-brain-permeability (logP=2.36±0.15; n=4).The in vivo stability of 7-131 I-FAUC 113 in tissuesamples wasassessed by radiotlc andradio-HPLCat20min p.i. (Fig. 3) . As shown in Fig. 3B ,the radioactivityinthe frontal cortex wasr eferredt oi ntactr adioligandand in the livertoalmost70% of recoveredradioactivity,whereas 7-131 I-FAUC 113 wasc ompletelya bsenti nb looda t2 0 min (Fig. 3D) . In accordancewith that, 54% of detected radioactivitywas determinedto be intact radiotracer in the blood pool at 10 minp.i. (radio-HPLC, Fig. 3E ).
Ex-vivo andin-vitro autoradiography
As determinedbyex-vivo autoradiography, the ratio of prefrontalcortextocerebellum (FC/CE)depictedamaximumat10min p. Tissue distribution of radioiodinated FAUC 113 within 10 min to avalue of about 1 (Fig. 4) . Representativesagittalbrain slices for control animals andanimalscoinjected with the D4-antagonistL -750,677 including the white-light imagesf or anatomical orientation areshown in Fig. 5A andFig. 5B,respectively. Forcoinjected (n=4)and control animals (n=6) ratios of regions of interest (ROI)for frontal cortex to striatum (FC/ST) andf rontalc ortext oc erebellum (FC/CE) were determined (Fig. 6) . Statistical analysiso ft hese ratios revealed no significant differenceb etween coinjected andc ontrol animals ( Fig. 6; p>0.1 ). In addition, we determinedt he dependenceo fr egional brain uptakev alueso nt he amount of injected radiolabelled ligandi nt hreei ndependent animals by using a14-20-foldincreased injected dose. Theanalysisofratios of ROIfor theseanimalsresultedinFC/CE=1.48±0.22 (n=3)and FC/ST=1.28±0.12 (n=3). In comparison with Fig. 6 , no significant alteration wasobservedw henincreasing the injected dose. In-vitro autoradiography revealed a maximumdisplacementrateof10-17% by the useofcold 7-iodo-FAUC113, whereas the presence of the sigma receptor agonist DTG (0.5µ mol/l) andt he serotonin antagonistp indolol( 0.1µ mol/l) or L-750,667 (5 µmol/l)h ad an even weaker effect on 7-131 I-FAUCbinding in ratbrain slices (Tab. 2).
Discussion
7-131 I-FAUCh as been characterized as a radioligandwith good blood-brain-permeability, rapid blood clearance andg ood in vivo stability using Sprague-Dawleyr ats. Ther easonf or high differences in the uptake valueso ft wo animals after5m in remainedunclear, however, the main degradation pathway for 7-131 I-FAUC1 13 was clearance via the bladder. Thebrain uptake of 7-131 I-FAUC113 wasinaccordancewith uptake valueso fe stablishedr adioligands, such as 18 F-MPPF,aspecific5-HT 1A radioligand (0.24 %ID/g, 15 minp.i., hippocampus) (28) .
Amore detailed comparison to structurally relatedradioligands wasdifficult dueto limiteddatainthe literature: Eskola et al.re- (Fig. 2) .
Ex-vivo autoradiography andcomparison to in-vitroresults
In ordertoinvestigatethe in-vivo specificity of I-FAUC113 we assessed the ratio of uptake valuesf or distinctr at brain regions morea ccurately by autoradiography.T his technique should yield moreprecise uptake valuesbyintegration of brainregionsonsagittal cryo sections comparedtoradioactive counts obtainedf rom dissected tissue samples of ratb rain. Fort his purposew e used the high-performance radio-imaging method of the µ-Imager(Biospace).This device couples athin scintillation sheet to an intensifiedC CD leading to significant improvement of spatialr esolutionf or most beta-emitting isotopes, especially suitedfor radio-imaging of low-expression levelsites (5).
The cerebellum wasr eported to represent an area without significant D4 receptor expression (30) . Therefore,weinvestigated the ratio of prefrontalcortextocerebellum (FC/CE)time-dependentlybyex-vivo autoradiography.I na ddition, rats were coinjected with 1mg/kg L-750667, aD4recep-tor antagonist ( 12) , in ordert ob lockp utative specific bindingof7-131 I-FAUC113. Sincethe ratstriatum also representsanarea of very little expression of the D4 receptor (23, 25) , the frontalcortex-to-striatum ratio wasadditionallyanalysed. Statistical analysiso ft hese ratios revealed no significant differenceb etween coinjected andc ontrol animals.F urthermore, a1 4-20-foldi ncreased injected doseo f7 -131 I-FAUC1 13 did not induce significant alterationso f tracer uptakei np utative receptor-positive brain regions as indicated by anon-varying FC/CEr atio. Thus, the increased FC/CE ratio of 7-131 I-FAUC113 at 10 minpostinjection (Fig. 4) could presumablyb ee xplainedb yh igher regionalb loodf lowo r capillary densityi nt he ratf rontalc ortex thani nc erebellum, andn ot by specific bindingo f7 -131 I-FAUC1 13. Although 7-131 I-FAUC1 13 andt he referencec ompound FAUC 113s howedh igh affinityi n the in-vitroassayusing membranesoftransfected CHO-cells stably expressing the dopamine D4 receptor subtype (18, 29), we did not observe selective binding on native rat brain tissues amples analysed by ex-vivo autoradiography.This observation could be due to the very lowD 4r eceptor density in ratbrain reportedtorange between 9and 30 fmol/mg (14, 30), so thatitisreasonableto supposet hats aturation of the D4 receptor could be reached with relatively low amounts of cold ligand.
Thee x-vivo autoradiography data were also consistent with the in-vitro autoradiography results using 7-131 I-FAUC1 13 ( Table 2 ).All the agents we used for binding inhibition studies with 7-131 I-FAUC113 on ratsagittalslices were ineffective, including 1,3-di-o -tolylguanidine (DTG, sigma receptor agonist) andpindolol(unselectiveserotonin antagonist), L-750667 (Fig. 1, D4 receptor antagonist) anda uthentic cold 7-iodo-FAUC 113 ( 29) . These results suggest nonspecificb inding of 7-131 I-FAUC 113. However, significant nonspecificbinding of I-FAUC113 to sigma or serotonin sitescan be excludedand ex-vivo autoradiography imagingalsodid notreveal any relevant uptakei nb rain regions whicha re untypical for D4 receptors. 7-131 I-FAUC 113 wasr atherc haracterized by rapid clearence from the brain.
The lossofregional specificity in blockademay also have resultedfrom • lowB max /K d ratio andt hus lowb inding potentialinvivoor • saturation of the entire population of dopamine D4 receptor subtypes.
Theconcentration of D4 subtypes in the cortexofrat brain averages 12.4pmol/g tissue (30) . In our experiments we determinedthe amount of cold ligandb yU V-absorbance (HPLC) detecting amaximum of 0.4nmol referedtothe sensitivity limit of UV-detection.Ifweassume 1%ID/g concentratedin the brain, the localized amount of cold ligandcan be estimatedat2pmol/g (0.01×0.4 ×10 -9 mol =2pmol/g). In consideration of the D4 affinityo f7 -131 I-FAUC( K i =2.6 nmol/l) the amount of cold ligandi nt he brain therefore could saturate the D4 receptorssignificantly. However, this assumption can be extrapolatedt oi nv ivoc onditions onlywith utmost caution,sincethe in vivo distribution of aradioligandatasingle time point is likelyt ob ei nfluenced by various factors besidesreceptor density andaffinity, such as blood flow,clearance of the radioligandand binding to nonspecificsites. 
